IVI RMA GLOBAL

What IVI RMA GLOBAL does

IVI RMA Global is a privately held reproductive medicine group operating the world's largest dedicated fertility treatment network. Formed in 2017 through the merger of Spain's IVI (founded 1990 by Profs. José Remohí and Antonio Pellicer) and the US-based RMA (founded 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews), the company runs more than 200 clinical offices and 95+ laboratories across 15 countries in Europe, North America, Latin America, and (as of late 2025) the Middle East, performing 200,000+ assisted reproduction treatments annually and producing 100+ births per day.

The group's clinical platform spans core ART services (in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, egg and sperm donation, fertility preservation including oocyte vitrification), advanced laboratory techniques (time-lapse embryo monitoring, MACS sperm selection, extended blastocyst culture), and a full genetic testing suite (PGT-A, PGT-SR, PGT-M, NIPT, carrier and sperm aneuploidy testing). It is supported by 7 research centers and 350+ researchers who have published 3,000+ scientific papers, alongside a global education division and the regional brands Boston IVF, Conceptions, Create Fertility, Genera, Demetra, Livio, Vitanova, Carl Von Linne, TRIO, Ferticare, Ginemed, Ginefiv, and Art Fertility.

IVI RMA generates revenue primarily from per-cycle clinical treatment fees across its global clinic network, supplemented by a recently launched US subscription membership product (with Costco and Sesame) priced at $99-$119 per month. The company is KKR-backed and has executed roughly $985M of M&A in 2025 alone, including the $535M Eugin North America acquisition and the ~$450M ART Fertility Clinics deal that established the Middle East as its fifth geographic region. Customers are overwhelmingly individual patients seeking fertility care, supplemented by enterprise partnerships with retailers, telehealth platforms, and advocacy organizations.

Name

IVI RMA GLOBAL

Legal name

EQUIPO IVI, S. L.

Website

https://www.ivirma.com/

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Reproductive Medicine / Fertility Services

NAICS

Family Planning Centers (621410), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Assisted reproductive technology
• In vitro fertilization
• Fertility treatment services
• Reproductive medicine clinics
• Fertility preservation services

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Fertility Treatment Services: IVI RMA Global generates revenue through providing assisted reproductive services including IVF, artificial insemination, egg donation, fertility preservation, and related treatments. Services are offered through a network of 200+ clinical offices across 15 countries.
2. Membership-based Fertility Care: Partnership with Costco and Sesame offers fertility care through a monthly membership model starting at $119 per month ($99 for Costco members), providing end-to-end fertility care including virtual access to reproductive specialists.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

IVI RMA Global operates a global network of fertility clinics providing assisted reproductive technology (ART) services including in vitro fertilization (IVF), artificial insemination, egg donation, fertility preservation, and preimplantation genetic testing. The group delivers these services through 200+ clinical offices and 95+ labs across 15 countries, supported by advanced laboratory techniques such as time-lapse embryo monitoring, ICSI, oocyte vitrification, MACS sperm selection, and extended embryo culture to blastocyst stage.

Product overview

IVI RMA Global is a comprehensive fertility care platform operating as the world's leading reproductive medicine group with a multi-brand, multi-region portfolio. The company offers a unified platform of assisted reproductive technology (ART) services comprising core clinical treatments (Artificial Insemination, In Vitro Fertilization, Egg Donation, Fertility Preservation), advanced laboratory techniques (Oocyte Vitrification, Time-Lapse Monitoring, ICSI, MACS, Extended Embryo Culture), and genetic testing services (PGT-A, PGT-SR, PGT-M, NIPT, Carrier Genetic Testing). The platform is organized across regional brands including IVI, RMA Network, Boston IVF, Conceptions, Ginemed, Ginefiv, Art Fertility, Create Fertility, Genera, Demetra, Livio, Vitanova, Carl Von Linne, TRIO Fertility, and Ferticare, spanning 15 countries with over 200 clinical offices and 95+ laboratories. The group also provides complementary services including global education programs (postgraduate studies, online courses, training & consulting) and research services through its Global Research Alliance (7 research centers, 15 research areas).

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF) A procedure uniting the ovum with the spermatozoon in the laboratory (in vitro) to obtain fertilized embryos for transfer to the mother's uterus, using either conventional IVF or ICSI. Offered to women and couples needing medical assistance to conceive.
• Artificial Insemination A procedure in which a prepared semen sample is deposited inside the woman's uterus to increase the potential of the spermatozoa and improve the chance of fertilization. Offered to couples and individuals seeking less invasive fertility treatment.
• Egg Donation
• Fertility Preservation
• Sperm Donation
• Preimplantation Genetic Testing for Aneuploidies (PGT-A) A test that detects numerical alterations in an embryo's chromosomes, identifying whether there are more or fewer chromosomes than the normal 46. Offered to patients undergoing IVF who wish to screen embryos for chromosomal abnormalities.
• Preimplantation Genetic Testing for Monogenic disorders (PGT-M) A test that detects alteration or mutation of a particular gene that would cause a monogenic or Mendelian disorder, including autosomal recessive, autosomal dominant, and X-chromosome-linked diseases.
• Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) A test that detects rearrangements in the structure of an embryo's chromosomes, which can result in infertility, repetitive miscarriages, or genetic disorders.
• Non-Invasive Prenatal Test (NIPT) A non-invasive prenatal screening test that analyses the most common chromosomal abnormalities including Down Syndrome, Edwards Syndrome, Patau Syndrome, and sex chromosome abnormalities.
• Carrier Genetic Test (CGT) A test to identify mutations present in an individual, detecting recessive and X-linked mutations to determine compatibility between partners for having children.
• Sperm Aneuploidy Test (SAT) A diagnostic test that studies sperm chromosomes to detect cases in which there is an abnormal number of chromosomes.
• Products of Conception (POC) Testing A test that analyses the foetal tissue of a gestational loss to determine whether the miscarriage was the result of a chromosomal aneuploidy.
• Costco Membership Fertility Care Plan Subscription-based end-to-end fertility care, including virtual access to reproductive specialists and connections to in-person clinic services for advanced treatment, offered exclusively to Costco members in the United States.
• IVI RMA Global Education Global education and training programs for reproductive medicine professionals, including postgraduate studies in collaboration with universities, online specialized courses, on-site clinic courses, and training and consulting services.
• IVI RMA Global Research Alliance The research division of IVI RMA Global with 7 research centers, 15 research areas, and over 150 researchers, dedicated to scientific research and technology development in reproductive medicine and ART.

Quantifiable outcome

• 100+ babies born daily thanks to IVI RMA Global
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Six partnerships are on record, tiered core and flagship.

• World Fertility Project / pregnantishcoreGTM or Marketing Partner · 10 June 2026IVI RMA Global is a campaign partner in the international 'Break the Taboo' campaign launching June 17, 2026, for World Infertility Awareness Month. The campaign builds on an inaugural campaign that engaged over 3 million people across six continents, with IVI RMA leveraging its international network of physicians, researchers, and clinics to amplify awareness of barriers to fertility care.
• CostcocoreGTM or Marketing Partner · 7 May 2026Costco partnered with Sesame and IVI RMA to offer affordable end-to-end fertility care through a monthly membership model starting at $119/month ($99 for Costco members). The partnership addresses a significant gap in employer fertility benefits, with IVF medications alone costing over $7,000 per cycle. Available exclusively to Costco members across the United States.
• SesamecoreGTM or Marketing Partner · 7 May 2026Healthcare self-pay marketplace partnered with Costco and IVI RMA to provide virtual access to reproductive specialists with connections to in-person clinic services for those needing specialized treatment. Addresses the high out-of-pocket costs associated with fertility treatments.
• RESOLVE: The National Infertility AssociationcoreGTM or Marketing Partner · 17 April 2026IVI RMA North America partnered with RESOLVE during National Infertility Awareness Week, with a portion of proceeds from the virtual pop-up shop donated to support infertility advocacy, education, and access to care.
• ART Fertility ClinicsflagshipStrategic or Co-development Partner · 11 February 2026IVI RMA Global completed approximately $450 million acquisition of ART Fertility Clinics operations across UAE and Saudi Arabia. The deal strengthens IVI RMA's presence in the GCC region and supports expansion plans into Saudi Arabia, establishing Middle East as its fifth geographic market.
• Eugin GroupflagshipStrategic or Co-development Partner · 22 January 2025IVI RMA America acquired Eugin Group's North American operations for $535 million, strengthening IVI RMA's presence in the North American fertility market.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Inception Fertility: Inception operates a large US fertility clinic network (including Prelude Fertility and MyEggBank), positioned similarly to IVI RMA's US footprint with multi-brand strategy and physician network rollup approach.
• TFP (The Fertility Partnership): TFP operates fertility clinics across the UK and parts of Europe, offering IVF, ICSI, and fertility preservation comparable to IVI RMA's UK (Create Fertility) and broader European footprint.
• The Fertility Partners: Canadian fertility clinic rollup backed by institutional capital pursuing the same multi-region consolidation strategy as IVI RMA Global, with acquired clinic brands retaining local identity.
• Prelude Fertility: Prelude operates a network of fertility clinics across the US focused on egg freezing and IVF, sitting under Inception Fertility but functioning as a comparable consumer-facing fertility brand like IVI RMA's RMA Network.
• Shady Grove Fertility: Shady Grove Fertility is one of the largest US fertility clinic operators, offering a comprehensive suite of IVF, IUI, donor egg, and genetic testing services with a shared-risk pricing program comparable to IVI RMA.
• New Hope Fertility Center: New Hope operates US fertility clinics emphasizing natural/minimal stimulation IVF protocols, overlapping with IVI RMA in core IVF services and competing for the same US patient population.
• Boston IVF (pre-acquisition context): Boston IVF is now a wholly owned brand within IVI RMA but historically operated as an independent competitor; it remains a useful peer reference for US regional fertility clinic scale and brand strength.
• CCRM Fertility: CCRM operates a multi-region fertility clinic network with in-house IVF labs, PGT services, and reproductive endocrinology specialists, directly competing with IVI RMA in the US market with comparable clinical offerings.

Others

• Vitrolife: Vitrolife is a leading supplier of ART media, consumables, and time-lapse incubator systems used by fertility clinics including IVI RMA; included as an adjacent ecosystem enabler in reproductive medicine.

Regional players

• Genea Group: Australian-headquartered fertility clinic operator with proprietary embryo culture technology and global licensing, comparable to IVI RMA as a multi-clinic ART provider, though primarily serving the Asia-Pacific region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries21 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IVI RMA GLOBAL